(Q50695738)

17 March 2018

title

Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results. (English)

1 reference

17 March 2018

Adaptive radiation therapy

main subject

0 references

hepatocellular carcinoma

1 reference

4

1 reference

17 March 2018

author name string

C Louis

1

1 reference

17 March 2018

S Dewas

2

1 reference

17 March 2018

X Mirabel

3

1 reference

17 March 2018

A Adenis

5

1 reference

17 March 2018

F Bonodeau

6

1 reference

17 March 2018

E Lartigau

7

1 reference

17 March 2018

publication date

1 October 2010

1 reference

17 March 2018

Technology in Cancer Research and Treatment

published in

1 reference

17 March 2018

volume

9

1 reference

17 March 2018

issue

5

1 reference

17 March 2018

page(s)

479-487

1 reference

17 March 2018

Treatment of hepatocellular carcinoma: is there an optimal strategy?

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Percutaneous radio-frequency ablation therapy using a clustered electrode for malignant liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Stereotactic body radiotherapy: an emerging treatment approach for localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Cyberknife radiosurgery for squamous cell carcinoma of vulva after prior pelvic radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Four-dimensional stereotactic radiotherapy for early stage non-small cell lung cancer: a comparative planning study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Hepatocellular carcinoma: present status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

An overview of hypofractionation and introduction to this issue of seminars in radiation oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Image-guided interstitial high-dose-rate brachytherapy in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Combination of sorafenib and intensity modulated radiotherapy for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Recent developments of targeted therapies in the treatment of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Platinum-based chemotherapy plus cetuximab in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

Erlotinib in lung cancer - molecular and clinical predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900506

10.1177/153303461000900506

21 January 2018

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018